Is oral leukoplakia easy to treat?
Feb 10, 2022
Source: Cainiu Health
Dr. Fu Gang
Introduction
Oral leukoplakia is characterized by oral pain and the presence of white granular lesions inside the mouth following disease onset. This condition does not resolve spontaneously. A critical aspect of treating oral leukoplakia is eliminating the harmful habit of smoking. In addition, pharmacological therapy may be used as an adjunctive treatment. With strict adherence to medical advice and regular follow-up visits, oral leukoplakia can be effectively controlled.
Oral leukoplakia is a type of oral white lesion disorder. The World Health Organization (WHO) classifies it as an oral potentially malignant disorder (OPMD), characterized by potential malignancy. Most cases of oral leukoplakia result from physical and chemical irritants, such as tobacco and betel nut. So, is oral leukoplakia treatable? Below, we address this question.
Is oral leukoplakia treatable?
Oral leukoplakia is a relatively common condition. Following onset, patients may experience oral pain and notice white, granular lesions inside the mouth. This condition does not resolve spontaneously. A critical aspect of treatment is cessation of smoking and other harmful habits. In addition, pharmacological therapy may be employed as adjunctive treatment. With strict adherence to medical advice and regular follow-up visits, oral leukoplakia can be effectively controlled.
Commonly used topical medications include tretinoin (vitamin A acid) ointment applied directly to the affected white areas, which helps normalize keratinization and reduce the whitish discoloration. Systemic treatments may include oral vitamin A, beta-carotene, and lycopene, combined with antioxidant agents such as vitamins C and E, to stabilize epithelial metabolism and reduce the risk of malignant transformation.
When oral leukoplakia exhibits poor tissue consistency or causes discomfort, clinicians often opt for surgical excision of the lesion followed by histopathological examination. Histopathology enables microscopic evaluation of epithelial dysplasia within the leukoplakia tissue, thereby clarifying the degree of dysplasia and guiding subsequent treatment and follow-up strategies. It remains the gold standard for diagnosing oral leukoplakia. However, not all leukoplakia lesions are suitable for excisional biopsy, nor does excision guarantee prevention of recurrence. Therefore, the decision to perform surgery—and the optimal timing—depends primarily on clinical judgment; patient preference serves only as a reference. Additionally, photodynamic therapy (PDT) is emerging as an adjunctive treatment modality for oral leukoplakia, with several reported cases demonstrating favorable therapeutic outcomes. Success hinges upon consultation with experienced specialists who can accurately assess and manage the condition.
The above provides an overview addressing the question, “Is oral leukoplakia treatable?” We hope this information proves helpful to you.
